Landscapes / Targets
PARP1
15 drugs act on PARP1, in 28 active trials · Any stage · updated 18 Nov 2026
FollowEvery change as it happens, and a Monday email
Drugs15
| Drug | How it works | Company | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
PARP inhibitor |
Approved in China | — | |||
| How it works | Blocks PARP | ||||
| Also tested for | Ovarian Cancer | ||||
| Open drug page | |||||
PARP inhibitor |
AstraZeneca · Public AZN |
Phase 3 | 28 May 2027Phase 1/2 trial completes | ||
| How it works | Blocks PARP | ||||
| Next date | 28 May 2027 · Phase 1/2 trial completes | ||||
| Also tested for | Prostate Cancer, Ovarian Cancer and 20 more | ||||
| Open drug page | |||||
— |
Hengrui · Public 600276.SS |
Phase 1/2 | Dec 2026Phase 1/2 trial completes | ||
| Next date | Dec 2026 · Phase 1/2 trial completes | ||||
| Also tested for | Prostate Cancer, Advanced Solid Tumors | ||||
| Open drug page | |||||
— |
Phase 2 | Mar 2027Phase 2 trial completes | |||
| Next date | Mar 2027 · Phase 2 trial completes | ||||
| Also tested for | Advanced Ovarian Cancer | ||||
| Open drug page | |||||
— |
Phase 1/2 | 1 Jun 2027Phase 1/2 trial completes | |||
| Next date | 1 Jun 2027 · Phase 1/2 trial completes | ||||
| Also tested for | Advanced Solid Tumor | ||||
| Open drug page | |||||
— |
Phase 1/2 | Dec 2028Phase 1/2 trial completes | |||
| Next date | Dec 2028 · Phase 1/2 trial completes | ||||
| Also tested for | Advanced Solid Tumors | ||||
| Open drug page | |||||
— |
Phase 1/2 | — | |||
| Also tested for | Advanced Malignant Neoplasm, Breast Cancer and 4 more | ||||
| Open drug page | |||||
— |
Phase 1/2 | — | |||
| Also tested for | Cancer, Neoplasms and 9 more | ||||
| Open drug page | |||||
— |
Phase 1 | Dec 2026Phase 1 trial completes | |||
| Next date | Dec 2026 · Phase 1 trial completes | ||||
| Also tested for | Advanced Cancer | ||||
| Open drug page | |||||
— |
Phase 1 | 22 Feb 2027Phase 1 trial completes | |||
| Next date | 22 Feb 2027 · Phase 1 trial completes | ||||
| Also tested for | Advanced Solid Tumor | ||||
| Open drug page | |||||
— |
Phase 1 | Aug 2028Phase 1 trial completes | |||
| Next date | Aug 2028 · Phase 1 trial completes | ||||
| Also tested for | Advanced Cancers (Breast, Ovarian, mCRPC, Pancreatic Ductal Adenocarcinoma (PDAC), Brain Mets) With Specific Mutations (Homologous Recombination Deficiency) | ||||
| Open drug page | |||||
— |
Gilead (Kite) · Public GILD |
Phase 1 | Sep 2028Phase 1 trial completes | ||
| Next date | Sep 2028 · Phase 1 trial completes | ||||
| Also tested for | Advanced Solid Tumors | ||||
| Open drug page | |||||
— |
Phase 1 | 30 Dec 2028Phase 1 trial completes | |||
| Next date | 30 Dec 2028 · Phase 1 trial completes | ||||
| Also tested for | Advanced Solid Tumor (Phase 1) | ||||
| Open drug page | |||||
— |
Phase 1 | — | |||
| Also tested for | Advanced Breast Cancer | ||||
| Open drug page | |||||
— |
Phase 1 | — | |||
| Also tested for | Ovarian Cancer, Breast Cancer and 9 more | ||||
| Open drug page | |||||
No drugs match “”.
About this list
- Checked
- 15 of 15 drugs. How we check
- Matches
- The mechanism of checked drugs, and drug names, so a drug not checked yet may be missing.
- Sources
- ClinicalTrials.gov updated 18 Nov 2026 · openFDA updated 17 Nov 2026